Search research articles
Contact Us
Filters
Showing results (31-40 of 41) with videos related to
Page
of 5
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 21, 2005
Antimicrobial prophylaxis in allogeneic bone marrow transplantation. Guidelines of the infectious diseases working party (AGIHO) of the german society of haematology and oncology
W H Krüger, J Bohlius, O A Cornely, et al.
Bone Marrow Transplantation
|
February 5, 2013
CD34(+) lineage specific donor cell chimerism for the diagnosis and treatment of impending relapse of AML or myelodysplastic syndrome after allo-SCT
F Rosenow, A Berkemeier, U Krug, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 8, 2016
CNS infections in patients with hematological disorders (including allogeneic stem-cell transplantation)-Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)
M Schmidt-Hieber, G Silling, E Schalk, et al.
Leukemia
|
April 2, 2011
Allogeneic stem cell transplant to eliminate germline mutations in the gene for CCAAT-enhancer-binding protein α from hematopoietic cells in a family with AML
M Stelljes, A Corbacioglu, R F Schlenk, et al.
Bone Marrow Transplantation
|
January 20, 2015
Treatment strategies in patients with AML or high-risk myelodysplastic syndrome relapsed after Allo-SCT
T Sauer, G Silling, C Groth, et al.
Deutsche Medizinische Wochenschrift (1946)
|
December 18, 2001
[Treatment of fungal infections in hematology and oncology. Guidelines of the Working Party on Infections in Hematology and Oncology (AGIHO) of the German Society for Hematology and Oncology (DGHO)]
A Böhme, M Ruhnke, M Karthaus, et al.
The Journal of Antimicrobial Chemotherapy
|
November 26, 2005
Caspofungin treatment in severely ill, immunocompromised patients: a case-documentation study of 118 patients
A Glasmacher, O A Cornely, K Orlopp, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|
June 20, 2002
Treatment of severe Candida infections in high-risk patients in Germany: consensus formed by a panel of interdisciplinary investigators
T Büchner, W Fegeler, H Bernhardt, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 25, 2018
Anti-infective vaccination strategies in patients with hematologic malignancies or solid tumors-Guideline of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO)
C T Rieger, B Liss, S Mellinghoff, et al.
Antimicrobial Agents and Chemotherapy
|
September 14, 2011
Phase II dose escalation study of caspofungin for invasive Aspergillosis
O A Cornely, J J Vehreschild, M J G T Vehreschild, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 41) with videos related to
Sort By:
Page
of 5
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 21, 2005
Antimicrobial prophylaxis in allogeneic bone marrow transplantation. Guidelines of the infectious diseases working party (AGIHO) of the german society of haematology and oncology
W H Krüger, J Bohlius, O A Cornely, et al.
Bone Marrow Transplantation
|
February 5, 2013
CD34(+) lineage specific donor cell chimerism for the diagnosis and treatment of impending relapse of AML or myelodysplastic syndrome after allo-SCT
F Rosenow, A Berkemeier, U Krug, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 8, 2016
CNS infections in patients with hematological disorders (including allogeneic stem-cell transplantation)-Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)
M Schmidt-Hieber, G Silling, E Schalk, et al.
Leukemia
|
April 2, 2011
Allogeneic stem cell transplant to eliminate germline mutations in the gene for CCAAT-enhancer-binding protein α from hematopoietic cells in a family with AML
M Stelljes, A Corbacioglu, R F Schlenk, et al.
Bone Marrow Transplantation
|
January 20, 2015
Treatment strategies in patients with AML or high-risk myelodysplastic syndrome relapsed after Allo-SCT
T Sauer, G Silling, C Groth, et al.
Deutsche Medizinische Wochenschrift (1946)
|
December 18, 2001
[Treatment of fungal infections in hematology and oncology. Guidelines of the Working Party on Infections in Hematology and Oncology (AGIHO) of the German Society for Hematology and Oncology (DGHO)]
A Böhme, M Ruhnke, M Karthaus, et al.
The Journal of Antimicrobial Chemotherapy
|
November 26, 2005
Caspofungin treatment in severely ill, immunocompromised patients: a case-documentation study of 118 patients
A Glasmacher, O A Cornely, K Orlopp, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|
June 20, 2002
Treatment of severe Candida infections in high-risk patients in Germany: consensus formed by a panel of interdisciplinary investigators
T Büchner, W Fegeler, H Bernhardt, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 25, 2018
Anti-infective vaccination strategies in patients with hematologic malignancies or solid tumors-Guideline of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO)
C T Rieger, B Liss, S Mellinghoff, et al.
Antimicrobial Agents and Chemotherapy
|
September 14, 2011
Phase II dose escalation study of caspofungin for invasive Aspergillosis
O A Cornely, J J Vehreschild, M J G T Vehreschild, et al.
Page
of 5